✦ LIBER ✦

Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML

✍ Scribed by Sébert, M; Porcher, R; Robin, M; Adès, L; Boissel, N; Raffoux, E; Xhaard, A; Dhedin, N; Larghero, J; Himberlin, C; Delmer, A; Fenaux, P; Dombret, H; Socié, G; de Latour, R P

Book ID: 126477222
Publisher: Nature Publishing Group
Year: 2014
Tongue: English
Weight: 387 KB
Volume: 50
Category: Article
ISSN: 0007-1188
DOI: 10.1038/bmt.2014.199

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival Advantage for Patients with AML

Survival Advantage for Patients with AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS after Transplantation

✍ Shimoni, Avichai; Shem-Tov, Noga; Volchek, Yulia; Danylesko, Ivetta; Yerushalmi, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

A Prospective Comparison Of Outcomes And

A Prospective Comparison Of Outcomes And Resource Utilization In Patients With Myeloid Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation (AlloHCT) Using Myeloablative Or Reduced Intensity Conditioning

✍ V. Gupta; T. Panzarella; L. Li; J. Khan; S. Alibhai; A. Galal; J. Kuruvilla; J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation (SCT) Using Fludarabine/Treosulfan Conditioning Regimen Compared With Busulfan-Based Myeloablative And Reduced-Intensity Conditioning In Patients With AML And MDS; Relative Outcomes Depend On Disease Status At SCT

✍ A. Shimoni; N. Shem-Tov; A. Rand; Y. Volchek; R. Yerushalmi; I. Hardan; A. Nagle 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A Prospective Study Comparing the Outcom

A Prospective Study Comparing the Outcomes and Health-Related Quality of Life in Adult Patients with Myeloid Malignancies Undergoing Allogeneic Transplantation Using Myeloablative or Reduced-Intensity Conditioning

✍ Vikas Gupta; Tony Panzarella; Le Li; Jabeen Khan; Ajay Sharma; Jeffrey H. Lipton 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 946 KB

Reduced-intensity vs myeloablative condi

Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

✍ Tanaka, J; Kanamori, H; Nishiwaki, S; Ohashi, K; Taniguchi, S; Eto, T; Nakamae, 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 442 KB

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th and 7th Decades of Life with AML or MDS Using Myeloablative, Reduced Toxicity IV Busulfan/Fludarabine (BuFlu) Conditioning Regimen

✍ G. Alatrash; B. Andersson; M. Pelosini; G. Rondon; M. Qazilbash; S. Giralt; L. d 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB